Marco Cattaneo

Marco Cattaneo

Università degli Studi di Milano

H-index: 90

Europe-Italy

About Marco Cattaneo

Marco Cattaneo, With an exceptional h-index of 90 and a recent h-index of 38 (since 2020), a distinguished researcher at Università degli Studi di Milano, specializes in the field of malattie emorragiche, trombosi, fisiopatologia delle piastrine, farmaci antiaggreganti piastrini, farmaci anticoagulanti.

His recent articles reflect a diverse array of research interests and contributions to the field:

The EHA research roadmap: blood coagulation and hemostatic disorders

Risk factors of recurrence in patients with cancer-associated venous thromboembolism

Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review

Echocardographic changes in anorexia nervosa: a pathophysiological adaptation or a disease?

An “unmodifiable” risk factor that has been modified

Diagnostic challenges in newborns and infants with coagulation disorders

Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial

Type and dose of heparin in Covid‐19: Reply

Marco Cattaneo Information

University

Position

Professore di Medicina Interna

Citations(all)

28463

Citations(since 2020)

8607

Cited By

24160

hIndex(all)

90

hIndex(since 2020)

38

i10Index(all)

268

i10Index(since 2020)

137

Email

University Profile Page

Università degli Studi di Milano

Google Scholar

View Google Scholar Profile

Marco Cattaneo Skills & Research Interests

malattie emorragiche

trombosi

fisiopatologia delle piastrine

farmaci antiaggreganti piastrini

farmaci anticoagulanti

Top articles of Marco Cattaneo

Title

Journal

Author(s)

Publication Date

The EHA research roadmap: blood coagulation and hemostatic disorders

HemaSphere

Sabine Eichinger

Pierre E Morange

Marco Cattaneo

Mathilde Fretigny

Antoine Rauch

...

2021/10/1

Risk factors of recurrence in patients with cancer-associated venous thromboembolism

European Journal of Internal Medicine

Yuji Nishimoto

Yugo Yamashita

Takeshi Morimoto

Yukihito Sato

Takeshi Kimura

2021/9/1

Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review

Simone Birocchi

Gian Marco Podda

Marco Manzoni

Giovanni Casazza

Marco Cattaneo

2021/2/17

Echocardographic changes in anorexia nervosa: a pathophysiological adaptation or a disease?

European Heart Journal-Cardiovascular Imaging

F Toriello

G Santangelo

F Bursi

E Epis

ME Tamagni

...

2021/1/1

An “unmodifiable” risk factor that has been modified

Internal and Emergency Medicine

Vincenzo Ronca

Gian Marco Podda

Marco Cattaneo

2021/1

Diagnostic challenges in newborns and infants with coagulation disorders

Wolfgang Eberl

2020/2

Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial

Blood Transfusion

Marco Cattaneo

Nuccia Morici

2020/5/7

Type and dose of heparin in Covid‐19: Reply

Journal of Thrombosis and Haemostasis

Jecko Thachil

Ning Tang

Satoshi Gando

Anna Falanga

Marcel Levi

...

2020/8/1

Patients with essential thrombocythemia may be poor responders to enteric-coated aspirin, but not to plain aspirin

Thrombosis and Haemostasis

Mariangela Scavone

Jessica Rizzo

Eti A Femia

Gian Marco Podda

Elena Bossi

...

2020/10

Platelet adhesion and thrombus formation in microchannels: the effect of assay-dependent variables

International Journal of Molecular Sciences

Mariangela Scavone

Silvia Bozzi

Tatiana Mencarini

Gianmarco Podda

Marco Cattaneo

...

2020/1/23

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

Journal of Thrombosis and Haemostasis

Christopher D Barrett

Hunter B Moore

Michael B Yaffe

Ernest E Moore

2020/8/1

Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified?

Thrombosis and haemostasis

Marco Cattaneo

Elena M Bertinato

Simone Birocchi

Carolina Brizio

Daniele Malavolta

...

2020/8

Long-Term Risk of Major Adverse Cardiovascular Events in Patients With Acute Coronary Syndrome: Prognostic Role of Complete Blood Cell Count

Angiology

Nuccia Morici

Valentina Molinari

Silvia Cantoni

Andrea Rubboli

Laura Antolini

...

2020/10

Report of a ‘consensus’ on the lines of treatment for primary immune thrombocytopenia in adults, promoted by the Italian Gruppo di Studio delle Piastrine

Lorenzo Cirasino

Anna M Robino

GianMarco Podda

Emmanuel Andrès

Jenny M Despotovic

...

2020/2/28

Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease …

Marco Cattaneo

Lina Badimon

Giancarlo Agnelli

Andrew T Chan

Angel Lanas

...

2020/1/13

DOACs and “newer” hemophilia therapies in COVID‐19: Reply

Journal of thrombosis and haemostasis

Jecko Thachil

Ning Tang

Satoshi Gando

Anna Falanga

Marco Cattaneo

...

2020/7/1

Hokusai post-PE study: a follow-up study on long-term outcomes of pulmonary embolism in patients treated with edoxaban vs warfarin

Ingrid Bistervels

Wim Boersma

Roisin Bavalia

Karina Meijer

Peter Verhamme

...

2020/9/7

Evaluation of platelet function in essential thrombocythemia under different analytical conditions

Platelets

Federico Lussana

Eti Alessandra Femia

Mariateresa Pugliano

Gianmarco Podda

Cristina Razzari

...

2020/2/17

Severe bleeding and absent ADP-induced platelet aggregation associated with inherited combined CalDAG-GEFI and P2Y12 deficiencies

haematologica

Barbara Lunghi

Anna Lecchi

Rosa Santacroce

Mariangela Scavone

Rita Paniccia

...

2020/7

Role of von Willebrand factor and ADAMTS-13 in the pathogenesis of thrombi in SARS-CoV-2 infection: time to rethink

Thrombosis and haemostasis

Nuccia Morici

Maurizio Bottiroli

Roberto Fumagalli

Claudia Marini

Marco Cattaneo

2020/9

See List of Professors in Marco Cattaneo University(Università degli Studi di Milano)